Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 10
Submit an article Journal homepage
32
Views
11
CrossRef citations to date
0
Altmetric
Research Article

A Pilot Study on Feasibility and Efficacy of Amifostine Preceding High-dose Melphalan with Autologous Stem Cell Support in Myeloma Patients

E. Jantunen Department of Medicine, Kuopio University Hospital, P.O. Box 1777, 70211 Kuopio, Finland
,
T. Kuittinen Department of Medicine, Kuopio University Hospital, P.O. Box 1777, 70211 Kuopio, Finland
&
T. Nousiainen Department of Medicine, Kuopio University Hospital, P.O. Box 1777, 70211 Kuopio, Finland
Pages 1961-1965 | Published online: 03 Aug 2009

  • [Line 10153]Harousseau, J.L., Milpied, N., Garand, R. and Bourhis, J.H. (1987) "High-dose melphalan and aulologous bone marrow transplantation in high-risk multiple myeloma", British Journal of Haematology 67, 493-496.
  • [Line 10184]Harousseau, J.L., Milpied, N., Laporte, J.P., Colombat, P., Facon, T., Tigaud, J.D., Casassus, P., Guilhot, F. and Ifrah, N. (1992) "Double intensive therapy in high-risk multiple myeloma". Blood 79, 2827-2933.
  • [Line 10220]Cunningham, D., Paz-Ares, L., Milan, S., Powles, R., Nicolson, M., Hickish, T., Selby, P., Treleaven, J., Viner, C., Malpas, J. Slevin, M., Findlay, M., Raymond, J. and Gore, M.H. (1994) "High-dose melphulan and aulologous bone marrow transplantation as consolidation in previously untreated myeloma". Journal of Clinical Ontology 12, 759-763.
  • [Line 10261]Barlogie, B., Jagannath, S., Vesole, D.H., Naucke, S. Cheson, B., Mauox, S., Bracy, D., Salmon, S., Jacobson, J., Crowley, J. and Tricot, G. (1997) "Superiority of tandem autolognus transplanuition over standard chemotherapy for previously untreated multiple myeloma". Blood 89, 789-793.
  • [Line 10299]Barlogie,. B., Jagannath, S., Desikan, K.R., Mattox, S., Vesole, D., Siegel. D., Tricot, G., Munshi, N., Passas, A., Singhai, S., Mehta, J., Anaissie, E., Dhodapkar, D., Naucke, S., Cramer, J., Sawyer, J., Epstein, J., Spoon, p., Ayers, D., Cheson, B. and Crowley, J. (1999) "Total therapy with tandern transplants for newly diagnosed multiple myeloma". Blood 93, 55-65.
  • [Line 10347]Altai, M., Harousseau, J.L., Stoppa, A.M., Sotto, J.J., Fuzibel, J.G., Rossi, J.F., Casassus, P., Maisonneuve, H., Facon, T. ltrah, N., Payen, C. and Bataille, R. (1996) "A prospective, randomized trial of aulologous bone marrow transplantation and chemotherapy in multiple myeloma". New England Journal of Medicine 335, 91-97.
  • [Line 10386]Samuels, B.L. and Bitran, J.D. (1995) "High-dose intravenous meIphalan a review". Journal of Clinical Oncology 13, 1786-1799.
  • [Line 10415]Moreau, P., Milpied, N., Mane, B., Juge Morineau, N., Rapp, M. J., Bataille, R. and Harousseau, J. -L. (1999) "Melphalan 220mg/m2 followed by peripheral blood stem cell transplantation in 27 patients with advanced multiple myeloma", Bone Marmw 'transplantation 23, 1003-1006.
  • [Line 10449]Milla,. J.L., McElwain, T.J., Clutterbuck, R.D. and Wist, E.A. (1982) "The modification of melphalan toxiciry in tumor bearing mice by S-2(3-aminopropylamino) ethylphosphorothioic acid (WR2721)". American Journal of Clinical Oncology 5, 321-328.
  • [Line 10480]Gover, D.J., Click, J.H., Weiler, C., Hurowitx. S. and Kligerman. M.M. (1986) "WR-2721 protects against hematologie toxicity of cyclophosphamide: a controlled phase Il trial". Journal of Clinical Oncology 4, 584-588.
  • [Line 10512]Aviles, A., Diaz-Maqueo, J.C., Talavera, A. Gracia, E.L., Guzman, R. and Nambo, M.J. (1997) "Bone marrow protection with amifixstine in the treatment of high-risk malignant lymphoma", European Journal of Cancer 33, 1323-1325.
  • [Line 10545]Kemp, G., Rose, P., Lurain, J., Bernmn, M. Marietta, A., Runllet, B., Homesley, H., Belpomme, D. and Click, J. (1996) "Amifostine pretreamient for protection against cyclophos-phamide-induced and cisplatin-induced toxidlies: results of a randomized control trial in patients with advanced ovarian cancer". Journal of Clinical Oncology 14, 2101-2112.
  • [Line 10581]Gore, m.E., Selby, P., Viner, C., Clark, P.I., Meldrum, M., Millar, B., Bell, J., Mailand, J.A., Milan, S., Judson, I.R., Zuiable, A., Tillyer, C., Slevin, M., Malpas, J.S. and McElwain, T.J. (1989) "Intensive treatment of multiple myeloma and criteria for complete remission". Lancet 2, 879-882.
  • [Line 10623]Schiller, J.H., Storer, B., Berlin, J., Whillenkeller, J., Larson, M., Phato, A., Larson, M. and Berry, W. (1996) "Amitostine. cispiatin. and vinblnstine in meiastalic non-small-cell lung cancer: a report of high response rate and prolonged survival". Journal of Clinical Oncology 14, 1913-1921.
  • [Line 10658]Capelli, D., Santini, G., De Souza, C, Poloni, A., Marino. G., Montanari, M., Lucesole, M., Brunori, M., Massidda, D., Offidani, M. Leoni, P. and Olivieri, A. (2000) "Amifostinc can reduce mucnsal damage after high-dose melphulan conditioning for peripheral blood progenitor cell aulolransplant: a retrospective study". British Journal of Haematology 110, 300-307.
  • [Line 10697]Adamson, P.C., Balis, F.M., Belavco, J.E., Lange, B., Berg. S.L., Blancy, S.M., Craig, C. and Poplack, D.G. (1995) "A phase I Trial of amifostine (WR 2721) and melphalan in children with refractory cancer". Cancer Research 55, 4069-4072.
  • Hilger. R.A., Szelenyi, H., Kreuser, E.D., Knauf, W.U., Scheulen, M., Schein, PS., Keilholz. U. and Thiel. E. (1999) "Influence of amifosline (Ethyol) on clinical and pharmacological data in patients with multiple myeloma treated with melphalan and peripheral blood stem cell transplantation (PBSC): a phase I trial". Prodeedings of ASCO, abstract 819.
  • [Line 10764]Patriarca, F. (1999) "Amifostine pretreatment for protection against melphalan + busulfan-induced toxicity in high-dose therapy for multiple myeloma patients". Blood 94 (Suppl. 1). 404S, abstract.
  • [Line 10791]Sonis, S.T.. Eilers, J.P., Epstein, J.B., LeVegue, FG., Liggett, W.H., Mulagha, M.T., Peterson, D.K., Rose, A.H., Schubert, M.M., Spijkervet, F.K. and Wittes, J.P. for the Mucositis Study Group (1999) "Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation and chemotherapy". Cancer 85, 2103-2113.
  • [Line 10830]Shuw, L.M., Bonner, U.S., Schuchter, L., Schiller, J. and Lieberman, R. (1999) "Pharmacokinetics of amifostine: effects of dose and method of administration". Seminars in Oncology 26(Suppl. 7), 34-36.
  • [Line 10863]Reece, D.E., Filicko, J., Flomenberg, N., Howard, D.S., Meisenherg, B., Plummer, B., Vesole, D., Xun, C.G. and Phillips, G.L. (2001) "Use of melphalan 280mg/m2: plus amifostine cytoprotection and autologous stem cell transplantation in multiple myeloma patients". Bloood 98. 196a. abstract.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.